Valuation GlaxoSmithKline Pharmaceuticals Limited

Stocks

Market Closed - Bombay S.E. 06:29:43 2026-08-21 am EDT			5-day change	1st Jan Change
2,899.60 ^INR	-3.35%		+7.83%	+17.35%

Aug. 03	GSK India first-quarter profit rises on steady vaccine demand	RE
Aug. 03	GlaxoSmithKline Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2026	CI

Data adjusted to current consolidation scope

Fiscal Period: March	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	281,714	224,319	329,173	487,432	386,822	491,210	-
Change	-	-20.37%	46.74%	48.08%	-20.64%	26.99%	-
Enterprise Value (EV)	256,351	207,663	329,173	487,432	386,822	491,210	491,210
Change	-	-18.99%	58.51%	48.08%	-20.64%	26.99%	0%
P/E	16.6x	36.7x	55.8x	52.5x	37.3x	42.3x	36.8x
PBR	10.6x	12.9x	18.5x	25x	17.1x	18.6x	15.6x
PEG	-	-0.6x	-16.49x	0.9x	3.2x	3.5x	2.4x
Capitalization / Revenue	8.59x	6.9x	9.53x	13x	10.1x	11.6x	10.4x
EV / Revenue	0x	0x	0x	0x	0x	11.6x	10.4x
EV / EBITDA	0x	0x	0x	0x	0x	33.2x	28.9x
EV / EBIT	0x	0x	0x	0x	0x	33.6x	28.9x
EV / FCF	0x	0x	0x	0x	0x	40.9x	37.3x
FCF Yield	2.75%	1.96%	1.67%	2.6%	2.19%	2.44%	2.68%
Dividend per Share ²	30	32	32	42	57	29.5	29.5
Rate of return	1.8%	2.42%	1.65%	1.46%	2.5%	1.02%	1.02%
EPS ²	100	36.05	34.83	54.76	61.15	68.52	78.88
Distribution rate	30%	88.8%	91.9%	76.7%	93.2%	43%	37.4%
Net sales ¹	32,780	32,517	34,537	37,492	38,217	42,528	47,167
EBITDA ¹	8,273	8,043	9,087	11,774	13,092	14,794	17,020
EBIT ¹	7,592	7,385	8,390	11,106	12,428	14,621	17,016
Net income ¹	16,947	6,107	5,900	9,276	10,360	11,611	13,364
Net Debt	-25,363	-16,656	-	-	-	-	-
Reference price ²	1,662.95	1,324.15	1,943.10	2,877.30	2,283.40	2,899.60	2,899.60
Nbr of stocks (in thousands)	169,406	169,406	169,406	169,406	169,406	169,406	-
Announcement Date	5/16/22	5/17/23	5/17/24	5/13/25	5/13/26	-	-

¹INR in Million²INR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
GLAXOSMITHKLINE PHARMACEUTICALS LIMITED	42.31x	-	-	1.02%	5.13B
ELI LILLY AND COMPANY	35.74x	12.95x	26.26x	0.55%	1,119B
JOHNSON & JOHNSON	30.06x	-	-	1.99%	651B
ABBVIE INC.	33.82x	7.82x	16.26x	2.59%	468B
ROCHE HOLDING AG	20.93x	4.96x	12.28x	2.66%	374B
NOVARTIS AG	22.59x	5.81x	14.4x	2.75%	302B
ASTRAZENECA PLC	21.37x	4.4x	12.49x	1.99%	259B
AMGEN INC.	27.79x	7.17x	12.73x	2.3%	238B
NOVO NORDISK A/S	13.71x	4.87x	10.23x	3.75%	208B
GILEAD SCIENCES, INC.	-44.65x	6.45x	25.18x	2.26%	181B
Average	20.37x	6.80x	16.23x	2.18%	380.5B
Weighted average by Cap.	25.53x	8.51x	18.70x	1.89%